Tag | Content |
---|
EnhancerAtlas ID | HS187-14699 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr2:225821510-225823340 |
| Number of super-enhancer constituents: 11 | ID | Coordinate | Tissue/cell |
SE_07445 | chr2:225822419-225824468 | Brain_Hippocampus_Middle_150 | SE_09679 | chr2:225821307-225825180 | CD14 | SE_10750 | chr2:225821165-225825020 | CD19_Primary | SE_11129 | chr2:225819355-225825449 | CD20 | SE_18264 | chr2:225821739-225824899 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19524 | chr2:225822078-225822928 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20427 | chr2:225821536-225823378 | CD56 | SE_22564 | chr2:225821850-225823604 | CD8_primiary | SE_45675 | chr2:225822051-225824380 | Osteoblasts | SE_61057 | chr2:225800738-225852069 | HBL1 | SE_62441 | chr2:225785791-225849599 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I224956 | chr2 | 225821463 | 225824683 |
|
Enhancer Sequence | TATTTTTATA CTGCACGGAG ATCTCATTTA TAAAATCAAA TATTCTCTTT TCCTAATGTA 60 TACTCAGTCA GGTGGAATTA ACTAACCAGC TGGATCACAC CGCATGTTTA GGAAATGGAG 120 GAGAAAACCC TGGAATAAAG CCAGCCTCTT CACTGGCCAC GGCTGTGCTT GGAATTTGTA 180 AACCTGGTCA TGCTTGTCAT GTCCCTCAGG TATTGTCTAA ATCAGGGTTT CTTAAACTCA 240 GCACTATTGA CATCTTGGAT CTGATCATTT GTTGTTTGTG TGTGGGGGTG TCCCTTGTAT 300 TGCAGGATGT TTTGTAGCAT CCCTGGCTGG CCTCTACCCA TGGATACCAG TAGCAAACTC 360 CCCGCCCTCT GCTGTGCCCA TCTGTGACAG CCACTGAGGT CCTCAGAAGT TGCCAAAACT 420 TCTTGGGGGA GGGCAGGGAA AAATCTCTCC CCAACCCTAG GTCTAAATCT AGTATTTAGT 480 TTTTACTTTC CGCCCCCCCC CGGCTTTGTT TTTCGGAGAT GGGGTCTCAC TCTGCCACCC 540 AGGCTAAAGT GCAGCGGTGT GATCATAGCT CACTGCAACC TTGAACTCTT GGGCTCAAAT 600 GACTCTCTTG CCTCAGCCTG CTGAGTAGCT GGGATTACAA ATGTGTATCA TCACACCTTT 660 TTTCATTTTA ATTTTTTTTG AGGTGGGGTC TTGCTATGTT GCCCAATCTA GTCTAGAACT 720 CCTGGTTTCA AGAGATCCTC TCACCTCAGC TTCCTGGTAG CTGAGATTAC AGGTGTGAGC 780 CACCAAATCC AGTATTTCCT TGATGATGGC TTCCAGAGCC AGGGATCTCC TGGCAGATGG 840 TGGAGATTTC TCTTTGGACC AGAGTTAGTA CCTCTTGAAA GCCGAGCTGA CTTGCTTGGA 900 AGAACCTCAG ACCTACTGTC CTTCAAATCA GTGCCCTCTT TCACTTCTCT ACATGTCTCA 960 AAACACCACT ATTCAAATTA GTGCATAAGC CTAGGTTTCT GTTTCTGTTC TGGGACGTCT 1020 CTATTAAAAT GCAGCTTCAC TTGCCTGGAA AAGCTACAAA CCCATTATAA TCTTCAATAA 1080 CTTAGAATAT TATCTCAGAA GAGGCAAACT GGTCACCTAG GCAAAGGCCC AAGGAATTGG 1140 GGATGAGGAT ACACGTTTCA AGCATGAAAG CATGTCATTG GGACTGTGGT GTTGGCCACT 1200 GTGGGTAAGA CCACTGTGCT GGCCTTCACA CTTACTTGCC AGGTACCTCT GGGTGACTTC 1260 CCTAACCTCT CTGGAAATGA GTCTCCTTAT CTGCAAAATA AAGATAACCA CAGTATCTAC 1320 TTTATTAGAT GTTGTGAGGC TTATTAATAG AATATTGGTG AAGTGCTTAG CGCCATGTGT 1380 GGAATATAAT AAAATGCTCA GTGGATGTCA GTTGTAAGTT GGATTATAAA GTAATTGTGT 1440 TGAGGTCATC TTGAGCTGCG CTGCTACAGT GTATGGTTTA TGAGTGCAGG ATGATCCTAG 1500 CTGCTCATGC ATTGAGCATT AGGAGGAGGA GCTCCGGGCA CAAAAAGGGC ACCAGCTCCG 1560 GGCACAAAAA GGGCACCTCG AAAGTGGCAG TGAAAGGAAT AGGATGCTTC AGAAAGGAAG 1620 GGAGTAGCCA GAAGACCCCT TGGTTTGGAT AAGGATAATT AGGTTAAACA GCCTCTCTTC 1680 CCCTGCACAC TCACTCCTTC CACAACTGAC CTCTTTGTGC TCATTGTGTC TTGCAACACT 1740 GGCTATTTCA TTTTTAAATC CCCTCTGTGC ACAACTACAA AAGGTTCCAA TTATCCTATT 1800 TCTGTCATCT CCCTTTATCC CACAAAGAAG 1830
|